Probi Agreement Furthers Probiotics in India
The probiotic supplier has signed a distribution agreement with a leading Indian healthcare company.
Probi AB (Lund, Sweden) has signed a distribution agreement with USV Ltd. (Mumbai, India) to allow the Indian pharmaceutical company to market digestive health probiotic products with Probi’s patented ingredients. Under the Vibact IBS brand, USV will launch supplements for irritable bowel syndrome and overall digestive health. One supplement will feature Probi’s Probi Digestis strain and another will feature Probi’s Lactobacillus plantarum 299v strain.
Recent study compares the effectiveness of two probiotic products on colicky infants
October 31st 2024The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.
New review paper highlights gut-brain benefits of novel herbal blend, Digexin
September 16th 2024NXT USA has announced the publication of a narrative review that offers an in-depth analysis of the efficacy and safety of its Digexin ingredient, which is a novel blend of Ashwagandha and okra extracts.
